<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_HKUST-Hong_Kong_overview_html"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:HKUST-Hong_Kong/overview.html">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:HKUST-Hong_Kong/overview.html&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:HKUST-Hong_Kong/overview.html&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:HKUST-Hong_Kong/overview.html&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:HKUST-Hong_Kong/overview.html" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:HKUST-Hong Kong/overview.html</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2011.igem.org</H3><P><FONT color="black"><B><FONT size="14">       Overview</FONT></B>  <A href="#back">Background</A> ·  <A href="#plan">The Battle Plan</A> ·  <A href="#build">Building the horse</A> ·  <A href="#army">The army inside</A></FONT></P><P><B>1. Background </B></P><P align="justify" style="margin: 20px 20px 20px 20px">
In the past decade, the number of medical cases involving multi-antibiotic resistant microbes has seen a steady increase, and misuse of antibiotics has repeatedly been mentioned as one of the major reasons for the arise of such organisms. This situation provided the inspiration for our project, which is to attempt to improve the effectiveness of antibiotics, so that we can apply less of it to achieve the same effect as we do now.
</P><P align="justify" style="margin: 20px 20px 20px 20px">
Our project name - E. trojan - has its origins rooted in the Trojan Horse found in the tale of the Trojan War. Similar to how the Greeks destroyed the city of Troy from within using a wooden horse filled with soldiers, our E. trojan also works to destroy an <I>E. coli</I>  population that is under antibiotic stress from within through indole quorum-sensing disruption.
<A href="#top">[Top]</A></P><P><B>2. The Battle Plan</B></P><P align="justify" style="margin: 20px 20px 20px 20px">
Indole has been proposed as a key signalling molecule for <I>E. coli</I> in mediating resistance to environmental stress.[1] In particular, indole is found to stimulate passive resistance against antibiotics by triggering stress-response mechanisms inside cells, including increased expression of drug efflux pumps and oxidative-damage repair systems. 
</P><P align="justify" style="margin: 20px 20px 20px 20px">
In a normal <I>E. coli</I>  population containing wild type and naturally resistant mutants, the mutants will supply indole to nearby cells that are under antibiotic stress. This is considered to be a 'charity' action as the mutant does so at a fitness cost to itself. Our aim is to introduce E. trojan into the population and proceed to degrade indole via an enzyme (T4MO) and remove the charity effect. If the charity effect is significant, removal of its presence will cause a notable increase in the effectiveness of antibiotics.
<A href="#top">[Top]</A></P><P><B>3. Building the horse - Engineering a novel strain for antibiotics-free selection</B></P><P align="justify" style="margin: 20px 20px 20px 20px">
To study the interaction and population dynamics of the naturally-coexisting HR (high resistance) and LR (low resistance) <I>E. coli</I> strains under antibiotic selection pressure, the E. trojan - which is to be introduced to HR/ LR mixed culture - should harbor the T4MO gene to allow it to perform quorum sensing disruption between the two strains. In addition, the E. trojan should not possess a wide spectrum of antibiotic resistance as this would give it an inherent selective advantage, thus interfering with the relationship between MICs and indole degradation in our study.
</P><P align="justify" style="margin: 20px 20px 20px 20px">
To fulfill the above criteria, it becomes necessary for us to first construct a new, pre-E. trojan bacterial strain (E. CRAFT) that is capable of performing plasmid selection without antibiotics and consequently contains as few antibiotic resistance genes as possible. Due to some limitations of the various alternative (non-antibiotic) selection methods[2] available today, we have designed E. CRAFT in a way that causes it to perform selection by imposing internal pressure of holding an essential gene for survival. Upon the completion of this precursor strain, the E. trojan can be easily constructed by transformation of the T4MO gene into it. In the long run, however, we hold a hope that this novel strain will prove to be a versatile, effective alternative to the widely- used antibiotic selection method.<A href="#top">[Top]</A></P><P><B>4. The army inside - Toluene-4-Monooxygenase (T4MO)</B></P><P align="justify" style="margin: 20px 20px 20px 20px">
Toluene-4-Monooxygenase (T4MO) is a three-component enzyme system that is naturally able to degrade a variety of hydrocarbons. In particular, its ability to oxidize small aromatic compounds has caught the attention of scientists looking for biological means of producing certain useful organic chemicals for industrial use, resulting in extensive research on modifying its activity and affinity. </P><P align="justify" style="margin: 20px 20px 20px 20px">
For our project, a mutated form of T4MO (double mutations at G103L &amp; A107G) was chosen as the candidate for indole degradation. While there were several possible candidates, this particular one was known to convert almost 50% of the indole into 7-hydroxyindole (7-HI)[2]. This is of great interest to us as 7-HI has been documented to inhibit biofilm formation in Enterohemorrhagic <I>E. coli</I>[3], and quite possibly for other strains of <I>E. coli</I> as well. Biofilm formation is a major element that reduces the efficiency of antibiotics due to reduced area of action, and hence we were keen to take advantage of this synergistic effect to improve our construct.<A href="#top">[Top]</A></P><P align="justify" style="margin: 20px 20px 20px 20px"><B>4.1 Soldiers need shields...maybe - Multidrug Efflux Pump (Bcr)</B></P><P align="justify" style="margin: 20px 20px 20px 20px">
As our novel strain will have one of its essential genes maintained in a plasmid, a lot of uncertainties are present regarding its fitness. It is quite possible that it will be more vulnerable to antibiotics compared with wild type and thus will be selected against when cultured together with wild type <I>E. coli</I>. This would reduce the effectiveness of our construct and is not desirable. Hence we planed an additional component to be maintained in the plasmid, known as Bcr, which we hope will boost the resistance of E. trojan. You will find more details on its construction <A href="asm.html" target="_top"><B>here</B></A>.<A href="#top">[Top]</A></P><P>
[1] <A href="http://www.nature.com/nature/journal/v467/n7311/pdf/nature09354.pdf">Bacterial charity work leads to population-wide resistance</A>
[2] <A href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941680/pdf/1475-2859-9-65.pdf">Antibiotic-free selection in <I>E. coli</I>: new considerations for optimal design and improved production</A>
[3] <A href="aem.asm.org/cgi/reprint/71/9/5476.pdf">Mutations of Toluene-4-Monooxygenase That Alter Regiospecificity of Indole Oxidation and Lead to Production of Novel Indigoid Pigments</A>
[4] <A href="aem.asm.org/cgi/reprint/73/13/4100.pdf">Enterohemorrhagic Escherichia coli Biofilms Are Inhibited by 7-Hydroxyindole and Stimulated by Isatin</A></P><TABLE border="0" cellspacing="0" cellpadding="10"><TBODY><TR><TD width="100px" height="150px"><P align="center"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong" target="_top"><B><FONT color="#FFE1E1" size="3">Home</FONT></B></A></P></TD><TD width="382px" bgcolor="#CCFF99" valign="baseline"><P align="center" valign="baseline"><B><FONT color="green">Our Project</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/overview.html" target="_top">Overview</A><FONT color="green"> | </FONT><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/data.html" target="_top">Data Page</A></P><P align="center" valign="baseline"><B><FONT color="green">Experiments and Results</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/asm.html" target="_top">Strain Construction</A><FONT color="green"> | </FONT><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/mic.html" target="_top">Culture Tests</A><FONT color="green"> | </FONT><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/modeling.html" target="_top">Modeling</A></P><P align="center" valign="baseline"><B><FONT color="green">Miscellaneous</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/notebook.html" target="_top">Notebook</A></P></TD><TD width="302px" bgcolor="#D09C00" valign="baseline"><P align="center" valign="baseline"><B><FONT color="#FFF4D0">iGEM Resources</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/acknowledgement.html" target="_top">Acknowledgements</A></P><P align="center" valign="baseline"><B><FONT color="#FFF4D0">The Team</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/team.html" target="_top">iGEM Member List</A><FONT color="#FFF4D0"> | </FONT><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/contribution.html" target="_top">Contributions</A></P><P align="center" valign="baseline"><B><FONT color="#FFF4D0">Achievements</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/medal.html" target="_top">Medal Requirements</A><FONT color="#FFF4D0"> | </FONT><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/biosafety.html" target="_top">BioSafety</A></P><P align="center" valign="baseline"><B><FONT color="#FFF4D0">BioBricks</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/characterization.html" target="_top">Master List &amp; Characterization Data</A></P></TD><TD width="180px" bgcolor="#980000" valign="baseline"><P align="center" valign="baseline"><B><FONT color="#FFE0E0">Human Practice</FONT></B></P><P align="center" valign="baseline"><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/workshop.html" target="_top">Workshop</A><FONT color="white"> | </FONT><A href="https://2011.igem.org/Team:HKUST-Hong_Kong/survey.html" target="_top">Survey</A></P></TD></TR></TBODY></TABLE><DIV class="printfooter">
Retrieved from &quot;<A href="http://2011.igem.org/Team:HKUST-Hong_Kong/overview.html">http://2011.igem.org/Team:HKUST-Hong_Kong/overview.html</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:HKUST-Hong_Kong/overview.html" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:HKUST-Hong_Kong/overview.html" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:HKUST-Hong_Kong/overview.html&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:HKUST-Hong_Kong/overview.html&amp;oldid=254118" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2011.igem.org:Privacy_policy" title="2011.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2011.igem.org:General_disclaimer" title="2011.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>